- Home
- KYTX vs SPKL Comparison
KYTX vs SPKL Comparison
Compare KYTX & SPKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- SPKL
- Stock Information
- Founded
- KYTX 2018
- SPKL 2021
- Country
- KYTX United States
- SPKL United States
- Employees
- KYTX N/A
- SPKL N/A
- Industry
- KYTX
- SPKL
- Sector
- KYTX
- SPKL
- Exchange
- KYTX NYSE
- SPKL Nasdaq
- Market Cap
- KYTX 196.4M
- SPKL 172.9M
- IPO Year
- KYTX 2024
- SPKL 2023
- Fundamental
- Price
- KYTX $3.98
- SPKL $10.59
- Analyst Decision
- KYTX Buy
- SPKL
- Analyst Count
- KYTX 5
- SPKL 0
- Target Price
- KYTX $23.20
- SPKL N/A
- AVG Volume (30 Days)
- KYTX 453.0K
- SPKL 23.4K
- Earning Date
- KYTX 02-12-2025
- SPKL 01-01-0001
- Dividend Yield
- KYTX N/A
- SPKL N/A
- EPS Growth
- KYTX N/A
- SPKL N/A
- EPS
- KYTX N/A
- SPKL 0.19
- Revenue
- KYTX N/A
- SPKL N/A
- Revenue This Year
- KYTX N/A
- SPKL N/A
- Revenue Next Year
- KYTX N/A
- SPKL N/A
- P/E Ratio
- KYTX N/A
- SPKL $57.13
- Revenue Growth
- KYTX N/A
- SPKL N/A
- 52 Week Low
- KYTX $3.63
- SPKL $10.13
- 52 Week High
- KYTX $30.60
- SPKL $11.95
- Technical
- Relative Strength Index (RSI)
- KYTX 38.40
- SPKL 56.23
- Support Level
- KYTX $3.63
- SPKL $10.57
- Resistance Level
- KYTX $4.60
- SPKL $10.60
- Average True Range (ATR)
- KYTX 0.45
- SPKL 0.01
- MACD
- KYTX -0.10
- SPKL 0.00
- Stochastic Oscillator
- KYTX 8.58
- SPKL 71.43
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About SPKL Spark I Acquisition Corp.
Spark I Acquisition Corp is a Blank check company.